Reid Huber

Currently

Active roles, board seats and partnerships.

Syremis Therapeutics

Director · 2025 – present

→

Merida Biosciences

CEO · Director · 2024 – present

→

Synnovation Therapeutics

Director · 2023 – present

→

Rapport Therapeutics

CEO · Director · 2022 – present

→

Asher Bio

Director · 2021 – present

→

Terremoto Biosciences

Director · 2021 – present

→

Moma Therapeutics

CEO · Director · 2020 – present

→

Partners HealthCare

Director · 2019 – present

venture_capital

→

Insitro

Board Observer · 2019 – present

→

Third Rock Ventures

Partner · 2018 – present

venture_capital

→

Work history

Past roles by Dealroom records.

Tango Therapeutics

Director · 2019 – 2023

→

The Andrew McDonough B+ Foundation

Director · 2017 – 2019

→

Bellicum Pharmaceuticals

Director · 2014 – 2024

→

Incyte

Director · President · VP · CSO · 2002 – 2018

→

Education